Airway Medix S.A. will obtain EUR 2 million for the development and commercialization of projects
Airway Medix signed two investment agreements with CoOpera, Kröner Medizintechnik and a Swiss group for up to EUR 2 million. The funds go into the development and commercialization of the company's three patented products.
Warsaw, November 16, 2023: Airway Medix has signed two Investment Agreements with CoOpera Finanzierungen Deutschland, Kröner Medizintechnik and a Swiss advisory and investment group. Partners will invest up to EUR 2 million, enabling the continuation of commercialization of innovative medical products on the EU, US, Asian and South American markets.
Three finished products, with international patents, focus on supporting patients' mechanical ventilation. Kröner Medizintechnik, CEO Peter Kröner, will be operationally and strategically involved in the company's development, covering production processes.
The partners, using their experience in the medical industry, granted the Company a EUR 900,000 loan, enabling it to complete negotiations and start business talks. The goal is to quickly commercialize products and develop synergies with partners' experience in the distribution of medical equipment.
About Airway Medix S.A.: Airway Medix S.A. focuses on the research, development and commercialization of innovative single-use devices for mechanically ventilated patients in Intensive Care Units (ICUs), as well as life-threatening patients and anesthesiology departments. The products offered by Airway Medix address the most pressing clinical needs and fill a gap in current medical devices. Airway Medix S.A. has been listed on the Warsaw Stock Exchange since 2014.
Press releases are published as issued by Airway Medix S.A. Product statements follow the instructions for use.
